APA-Zitierstil (7. Ausg.)

Requena, G., Czira, A., Banks, V., Wood, R., Tritton, T., Castillo, C., . . . Ismaila, A. S. (2023). Comparative effectiveness of umeclidinium/vilanterol versus indacaterol/glycopyrronium on Moderate-to-severe exacerbations in patients with chronic obstructive pulmonary disease in clinical practice in England. The International journal of chronic obstructive pulmonary disease, Volume 18, . https://doi.org/10.2147/COPD.S408688

Chicago-Zitierstil (17. Ausg.)

Requena, Gema, et al. "Comparative Effectiveness of Umeclidinium/vilanterol Versus Indacaterol/glycopyrronium on Moderate-to-severe Exacerbations in Patients with Chronic Obstructive Pulmonary Disease in Clinical Practice in England." The International Journal of Chronic Obstructive Pulmonary Disease Volume 18 (2023). https://doi.org/10.2147/COPD.S408688.

MLA-Zitierstil (9. Ausg.)

Requena, Gema, et al. "Comparative Effectiveness of Umeclidinium/vilanterol Versus Indacaterol/glycopyrronium on Moderate-to-severe Exacerbations in Patients with Chronic Obstructive Pulmonary Disease in Clinical Practice in England." The International Journal of Chronic Obstructive Pulmonary Disease, vol. Volume 18, 2023, https://doi.org/10.2147/COPD.S408688.

Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.